Authors: HERMANS P FRANCHIOLY P THIOUX C GRAY SJ VANNEROM H CLUMECK N

Citation: P. Hermans et al., MINIMUM EFFECTIVE DOSE AND DURATION TO REVERSE NEUTROPENIA IN NONCANCER PATIENTS WITH ADVANCED HIV DISEASE, AIDS, 10(9), 1996, pp. 1050-1051

Authors: MASCARTLEMONE F GERARD M LIBIN M CRUSIAUX A FRANCHIOLY P LAMBRECHTS A GOLDMAN M CLUMECK N

Citation: F. Mascartlemone et al., DIFFERENTIAL EFFECT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON THE IGA AND IGG ANTIBODY-RESPONSES TO PNEUMOCOCCAL VACCINE, The Journal of infectious diseases, 172(5), 1995, pp. 1253-1260

Authors: HERMANS P BEX F BIEVA C FRANCHIOLY P BADJOU R ACHOUR A SPRECHER S CLUMECK N BURNY A

Citation: P. Hermans et al., COMPARISON BETWEEN AUTOLOGOUS AND SYNGENIC TRANSFERS OF CD8-TWINS( CELLS IN IDENTICAL), AIDS research and human retroviruses, 10, 1994, pp. 190000029-190000029

Authors: HERMANS P GORI A LEMONE M FRANCHIOLY P CLUMECK N

Citation: P. Hermans et al., POSSIBLE ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ON THE RAPID PROGRESSION OF AIDS-RELATED KAPOSIS-SARCOMA LESIONSIN-VIVO, British Journal of Haematology, 87(2), 1994, pp. 413-414